
NASDAQHealthcareMedical - Instruments & Supplies
最新データ
$8.24
+$0.11 · +1.35%
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
前日終値
$8.24
+$0.11 · +1.35%
日中の時刻はETです。市場データは遅延する場合があります。
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
日中レンジ
現在 $8.24
52週レンジ
現在 $8.24
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
46
適正価値
センチメント
51
まちまち
リスク
67
高リスク
モメンタム
44
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
日中レンジ
現在 $8.24
52週レンジ
現在 $8.24
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 8655万 USD | 9413.5万 USD | 1.12億 USD | 1.13億 USD | 1.19億 USD |
| 売上原価 | 4066.7万 USD | 3936.9万 USD | 4617.9万 USD | 5251.6万 USD | 5125.2万 USD |
| 粗利益 | 4588.3万 USD | 5476.6万 USD | 6607.1万 USD | 6081.9万 USD | 6765.2万 USD |
| 研究開発 | 882.5万 USD | 1040.6万 USD | 1176.4万 USD | 1232.9万 USD | 1079.9万 USD |
| 販売・一般管理 | 3695.8万 USD | 4370.5万 USD | 4688.8万 USD | 4953.4万 USD | 4894.7万 USD |
| 営業費用 | 4651.2万 USD | 6097.7万 USD | 6417.7万 USD | 6775.2万 USD | 6558.6万 USD |
| 支払利息 | 491.7万 USD | 320.9万 USD | 359.1万 USD | 254.8万 USD | 154万 USD |
| 減価償却費と償却費 | 594.5万 USD | 715.7万 USD | 699.8万 USD | 757.5万 USD | 762.1万 USD |
| 営業利益 | −62.9万 USD | −621.1万 USD | 189.4万 USD | −693.3万 USD | 206.6万 USD |
| 純利益 | −5670万 USD | −1240.5万 USD | −341.5万 USD | −951.6万 USD | −28.8万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$38.00
上昇余地(361.17%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2026年3月16日 | 1:10 | — | — |
株式分割 | 2013年11月4日 | 1,319:1,000 | — | — |
発効済み 2026年3月16日
1:10
発効済み 2013年11月4日
1,319:1,000
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI100.13万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF34.1万0.00%954億 USD0.05%$235+0.80%
Dimensional - US Sustainability Core 1 ETFDFSU1.55万0.00%23.92億 USD0.15%$48.11+0.48%
Dimensional - US Small Cap ETFDFAS1.32万0.00%338.69億 USD0.31%$78.35+0.32%
U.S. Vector Equity Portfolio ETF Class SharesDXUV9991.770.00%61.81億 USD0.26%$68.28+0.25%
Dimensional - US Core Equity 2 ETFDFAC8365.770.00%885.96億 USD0.21%$45.33+0.49%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR7544.640.00%455.91億 USD0.17%$84.44+0.44%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
Dimensional - US Sustainability Core 1 ETFDFSU
Dimensional - US Small Cap ETFDFAS
U.S. Vector Equity Portfolio ETF Class SharesDXUV
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。